Lupus Erythematosus, Discoid
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results show that p36 is a new interferon-alpha-induced protein that localizes in the endoplasmic reticulum, the cell region in which the lupus inclusions form, and that p36 is probably physically associated with the lupus inclusions.
|
8557639 |
1996 |
Lupus Erythematosus, Systemic
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results show that p36 is a new interferon-alpha-induced protein that localizes in the endoplasmic reticulum, the cell region in which the lupus inclusions form, and that p36 is probably physically associated with the lupus inclusions.
|
8557639 |
1996 |
Lupus Vulgaris
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results show that p36 is a new interferon-alpha-induced protein that localizes in the endoplasmic reticulum, the cell region in which the lupus inclusions form, and that p36 is probably physically associated with the lupus inclusions.
|
8557639 |
1996 |
Malaria
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
The proteins P52 and P36 are expressed in the sporozoite stage of the murine malaria parasite Plasmodium berghei.
|
23227206 |
2012 |
Malaria
|
0.020 |
Biomarker
|
disease |
BEFREE |
A protein called P36 holds the key to how different species of malaria parasite invade liver cells.
|
28614050 |
2017 |
Malignant neoplasm of brain
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The p36 region of chromosome one has been reported to have frequent loss of heterozygosity (LOH) in brain and central nervous system (CNS) tumors and epidemiological studies have shown an increased relative risk of BC and tumors of the CNS in PC families.
|
11536309 |
2001 |
Malignant neoplasm of prostate
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The p36 region of chromosome one has been reported to have frequent loss of heterozygosity (LOH) in brain and central nervous system (CNS) tumors and epidemiological studies have shown an increased relative risk of BC and tumors of the CNS in PC families.
|
11536309 |
2001 |
Malignant Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
The presence of 1p abnormalities in AML and other malignancies is reviewed, as are candidate tumor suppressor genes in the 1p34 approximately p36 region.
|
12547161 |
2002 |
Malignant Neoplasms
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Southern analysis of cancer DNA showed no noticeable deletion in p36 gene.
|
11522620 |
2001 |
Malignant transformation
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
We report here the initial description of the association of increased p36 expression with malignant transformation.
|
2160596 |
1990 |
Massive Osteolyses
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutations in P36 and P46 lead to glycogen storage disease (GSD) type-1a and type-1 non a (formerly 1b and 1c), respectively.
|
10712583 |
2000 |
Mycobacterium Infections
|
0.010 |
Biomarker
|
group |
BEFREE |
Furthermore, the reactivity of antibodies in sarcoid patient sera against p36 and PTB65K antigens was comparable to the reactivity of sera obtained from patients with known mycobacterial disease.
|
8862592 |
1996 |
Mycoplasma Infections
|
0.010 |
Biomarker
|
group |
BEFREE |
In conclusion we have shown that P36 is a protein that is a common antigen of M. hyopneumoniae strains and is not found in other Mycoplasma or Acholeplasma species tested.
|
1723490 |
1991 |
Neoplasms
|
0.050 |
GeneticVariation
|
group |
BEFREE |
The p36 region of chromosome one has been reported to have frequent loss of heterozygosity (LOH) in brain and central nervous system (CNS) tumors and epidemiological studies have shown an increased relative risk of BC and tumors of the CNS in PC families.
|
11536309 |
2001 |
Neoplasms
|
0.050 |
GeneticVariation
|
group |
BEFREE |
LOH at 1 p36 retained independent prognostic significance in a multivariate model that included KIT mutation status and tumor size; the mitotic index, however, did not retain independent significance in such a model.
|
10616197 |
1999 |
Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
Loss of heterozygosity (LOH) involving the distal chromosome 1 p36 region occurs frequently in nonastrocytic brain tumours, but the tumour suppressor gene targeted by this deletion is unknown. p73 is a novel gene that has high sequence homology and similar gene structure to the p53 gene; it has been mapped to 1 p36, and may thus represent a candidate for this tumour suppressor gene.
|
11461077 |
2001 |
Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
The presence of 1p abnormalities in AML and other malignancies is reviewed, as are candidate tumor suppressor genes in the 1p34 approximately p36 region.
|
12547161 |
2002 |
Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
Cytogenetic and molecular studies in neuroblastoma suggest the presence of a tumor suppressor gene at the distal band p36 of human chromosome 1.
|
7700633 |
1995 |
Neuroblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
LOH at 1p36 was found in 24 of 80 cases, suggesting the possibility of a tumor suppressor gene at 1 p36 near the site of a suspected neuroblastoma tumor suppressor gene.
|
10616197 |
1999 |
Neuroblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Cytogenetic and molecular studies in neuroblastoma suggest the presence of a tumor suppressor gene at the distal band p36 of human chromosome 1.
|
7700633 |
1995 |
Neuroectodermal Tumor, Primitive
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Instead, p36 gene expression was modulated in both proliferating and non-proliferating PNET cell cultures by treatment with 50 mIU/ml of insulin, 100 mM ethanol, or 5 microM retinoic acid.
|
7738588 |
1995 |
Osteosarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Comparative genomic hybridization analysis identifies gains of 1p35 approximately p36 and chromosome 19 in osteosarcoma.
|
11672768 |
2001 |
Osteosarcoma of bone
|
0.010 |
Biomarker
|
disease |
BEFREE |
Comparative genomic hybridization analysis identifies gains of 1p35 approximately p36 and chromosome 19 in osteosarcoma.
|
11672768 |
2001 |
Paratuberculosis
|
0.020 |
Biomarker
|
disease |
BEFREE |
Characterization of Mycobacterium paratuberculosis p36 antigen and its seroreactivities in Crohn's disease.
|
10398839 |
1999 |
Paratuberculosis
|
0.020 |
Biomarker
|
disease |
BEFREE |
Specific seroreactivity of Crohn's disease patients against p35 and p36 antigens of M. avium subsp. paratuberculosis.
|
11118734 |
2000 |